Found: 13
Select item for more details and to access through your institution.
Corrigendum: An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1479557
- By:
- Publication type:
- Article
An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis Updated.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2022.1037983
- By:
- Publication type:
- Article
Corrigendum: An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1479557
- By:
- Publication type:
- Article
An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2022.1037983
- By:
- Publication type:
- Article
An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1037983
- By:
- Publication type:
- Article
Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Differential roles of CTP synthetases CTPS1 and CTPS2 in cell proliferation.
- Published in:
- Life Science Alliance, 2023, v. 6, n. 9, p. 1, doi. 10.26508/lsa.202302066
- By:
- Publication type:
- Article
Collagen II antibody-induced arthritis in Tg1278TNFko mice: optimization of a novel model to assess treatments targeting human TNFα in rheumatoid arthritis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The Use of Surrogate Antibodies to Evaluate the Developmental and Reproductive Toxicity Potential of an Anti-TNFα PEGylated Fab′ Monoclonal Antibody.
- Published in:
- Toxicological Sciences, 2011, v. 122, n. 1, p. 170, doi. 10.1093/toxsci/kfr083
- By:
- Publication type:
- Article
A PEGylated Fab′ Fragment against Tumor Necrosis Factor for the Treatment of Crohn Disease: Exploring a New Mechanism of Action.
- Published in:
- BioDrugs, 2008, v. 22, n. 5, p. 331, doi. 10.2165/00063030-200822050-00005
- By:
- Publication type:
- Article
Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20828-3
- By:
- Publication type:
- Article
A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20825-6
- By:
- Publication type:
- Article
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-13616-1
- By:
- Publication type:
- Article